UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047111
Receipt number R000053719
Scientific Title Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease
Date of disclosure of the study information 2022/03/07
Last modified on 2025/04/21 07:40:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease

Acronym

Effect of nerve block on Parkinson's disease

Scientific Title

Examination of nerve block effect on abdominal pain and low back pain in Parkinson's disease

Scientific Title:Acronym

Effect of nerve block on Parkinson's disease

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For patients with Parkinson's disease who complain of chronic abdominal pain and low back pain, block injection and trigger point injection to the anterior cutaneous nerve will be performed to evaluate the effect on pain and the effect on Parkinson's symptoms including posture abnormalities.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain Questionnaire including visual analogue scale
(2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)

Key secondary outcomes

Unified Parkinson Disease Rating Scale, functional evaluation in rehabilitation, evaluation of waist bending angle
(2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with Parkinson's disease by the British Brain Bank Clinical Criteria
2) H & Y classification II degree or higher
3) Patients aged between 20 and 85 at the time of consent
4) Gender does not matter
5) Patients who have voluntarily consented to the document

Key exclusion criteria

1) Patients with serious physical symptoms other than Parkinson's disease (cardiac / hepatic / renal dysfunction, hematopoietic disorders, etc.)
2) Viral hepatitis: HBsAg positive or HCV antibody positive
3) Women who are pregnant or may become pregnant
4) Patients with a history of hypersensitivity to the study drug
5) Patients with drug addiction / alcohol dependence
6) Patients with serious psychiatric symptoms (confusion, hallucinations, delusions, abnormal behavior, etc.) within 3 months before obtaining the consent form
7) Other patients who the doctor in charge deems inappropriate to participate in the study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takuyuki
Middle name
Last name Endo

Organization

Osaka Toneyama Medical Center

Division name

Neurology

Zip code

565-0873

Address

5-1-1, Toneyama, Toyonaka, Osaka

TEL

+81-6-6853-2001

Email

endo.takuyuki.gr@mail.hosp.go.jp


Public contact

Name of contact person

1st name Takuyuki
Middle name
Last name Endo

Organization

Osaka Toneyama Medical Center

Division name

Neurology

Zip code

565-0873

Address

5-1-1, Toneyama, Toyonaka, Osaka

TEL

+81-6-6853-2001

Homepage URL


Email

endo.takuyuki.gr@mail.hosp.go.jp


Sponsor or person

Institute

Osaka Toneyama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of
Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Toneyama Medical Center Clinical Research Review Committee

Address

5-1-1, Toneyama, Toyonaka, Osaka

Tel

06-6853-2001

Email

410-chiken@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 05 Month 18 Day

Date of IRB

2018 Year 05 Month 18 Day

Anticipated trial start date

2018 Year 05 Month 18 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry

2026 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Observation period, 24 weeks
Inspection items
Background of research subjects
Diagnostic imaging
Chest X-ray, thoracolumbar MRI
Clinical examination
Hematological tests
electrocardiogram
Questionnaire for anesthesiology pain clinic
Evaluation of neurological symptoms
Evaluation in the rehabilitation department, 10m walking, 3m Time-up-go test
Pain Visual Analogue Scale, photos for posture evaluation


Management information

Registered date

2022 Year 03 Month 07 Day

Last modified on

2025 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053719